Clinical Trial Update: Dose Ranging Study of OTO-201 in AOMT [Phase 2]

View source ↗

Summary

Phase 2 dose-ranging study of OTO-201 in Acute Otitis Media (AOM) and AOMT has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Otitis Media

Drugs mentioned

• OTO-201

Snippet

Sponsor: Otonomy, Inc. | Conditions: Acute Otitis Media, AOMT | Phase 2 | Status: COMPLETED | Results posted: 2020-09-24